Publications by authors named "Bruce Lavin"

Claim this Profile
T
Telemedicine and Epilepsy Care.
Bruce Lavin, Cloe L Gray, Martin Brodie

Neurol Clin· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bridging the healthcare gap: Building the case for epilepsy virtual clinics in the current healthcare environment.
Bruce Lavin, Cassie Dormond, Morris H Scantlebury, Pierre-Yves Frouin, Martin J Brodie

Epilepsy Behav· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Report on Electroencephalographic Findings in Critically Ill Patients with COVID-19.
Hervé Vespignani, Damien Colas, Bruce S Lavin, Christine Soufflet, Louis Maillard

Ann Neurol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changing the neurology policy landscape in the United States: Misconceptions and facts about epilepsy.
David C Grabowski, Jesse Fishman, Imane Wild, Bruce Lavin

Health Policy· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A disease model descriptive of progression between chronic obstructive pulmonary disease exacerbations and community-acquired pneumonia: roles for underlying lung disease and the pharmacokinetics/pharmacodynamics of the antibiotic.
Thomas M File, Scott V Monte, Jerome J Schentag, Joseph A Paladino, Keith P Klugman, Bruce Lavin

Int J Antimicrob Agents· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Streptococcus pneumoniae bacteraemia: pharmacodynamic correlations with outcome and macrolide resistance--a controlled study.
Jerome J Schentag, Keith P Klugman, Victor L Yu, Martin H Adelman, Gregory J Wilton, Bruce Lavin

Int J Antimicrob Agents· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in anti-bacterial resistance among Streptococcus pneumoniae isolated in the USA, 2000-2003: PROTEKT US years 1-3.
Stephen G Jenkins, David J Farrell, Manish Patel, Bruce S Lavin

J Infect· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The bioequivalence of telithromycin administered orally as crushed tablets versus tablets swallowed whole.
Christina Lippert, Seth Gbenado, Chunfu Qiu, Bruce Lavin, Steven J Kovacs

J Clin Pharmacol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emergence and spread of Streptococcus pneumoniae with erm(B) and mef(A) resistance.
David J Farrell, Stephen G Jenkins, Steven D Brown, Manish Patel, Bruce S Lavin

Emerg Infect Dis· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meta-analysis of bacterial resistance to macrolides.
Michael T Halpern, Jordana K Schmier, Lia M Snyder, Carl Asche, Phillip W Sarocco, Bruce Lavin

J Antimicrob Chemother· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia.
Guy Tellier, Michael S Niederman, Roomi Nusrat, Manish Patel, Bruce Lavin

J Antimicrob Chemother· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hospitalization rates among patients with community-acquired pneumonia treated with telithromycin vs clarithromycin: results from two randomized, double-blind, clinical trials.
Michael S Niederman, Joanne R Chang, John Stewart, Carl V Asche, Bruce Lavin

Curr Med Res Opin· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of hospitalization rates in patients with community-acquired pneumonia treated with telithromycin for 5 or 7 days or clarithromycin for 10 days.
Guy Tellier, Joanne R Chang, Carl V Asche, Bruce Lavin, John Stewart

Curr Med Res Opin· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endocarditis due to vancomycin-resistant Enterococcus faecium in an immunocompromised patient: cure by administering combination therapy with quinupristin/dalfopristin and high-dose ampicillin.
Robert L Thompson, Bruce Lavin, George H Talbot

South Med J· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis